Protective and health-promoting impact of Washingtonia filifera oil on the kidney of STZ-induced diabetic mice

Abstract

AbstractDiabetes kidney damage (DKD) is a chronic inflammatory disease of the kidney induced with continuous hyperglycemia as the most prevalent consequence of diabetes. Washingtonia filifera seed oil (WFO) was used as a traditional medicine to cure various diseases in ancient Saudi. This work was carried out to investigate the potential protective impact of WFO against DKD on streptozotocin (STZ)-induced type 2 diabetic mice (C57BL/6 mice). The mice were randomly split into groups: C, C + WFO (200 mg/Kg B.W.), T2D, and T2D + WFO (200 mg/Kg B.W.). Diabetes was created in mice groups except for the control group after 6 weeks of high-fat diet (HFD) feeding. Treatments with STZ (60 mg/kg body weight) were administered three times for 6 weeks, and after that, mice were sacrificed. Kidney tissues and serum were obtained to analyze levels of insulin, metabolism of lipids [triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and free fatty acids (FFA)], antioxidant enzymes [superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx)], creatine, and blood urea nitrogen (BUN). In addition, H&E staining had been used to investigate the histological changes of the kidneys. In T2D mice, WFO corrected aberrant serum lipids (TG, TC, HDL, LDL, and FFA), elevated antioxidative enzyme levels (CAT, SOD, and GPx), and inhibited GST to various degrees. In addition, WFO improves kidney pathological traits such as fibrosis of the kidney, hypertrophy of glomeruli, and basement membrane thickness of glomeruli. Through hypoglycemic, hypolipidemic, antioxidative, and anti-inflammatory actions, WFO might ameliorate diabetic alterations in T2D mice. WFO could significantly reduce AGE buildup in the T2D mice kidneys, therefore alleviating kidney oxidative stress and inflammatory kidney damage.